Literature DB >> 16912271

Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle.

Brigit E Riley1, Harry T Orr.   

Abstract

The polyglutamine disorders are a class of nine neuro-degenerative disorders that are inherited gain-of-function diseases caused by expansion of a translated CAG repeat. Even though the disease-causing proteins are widely expressed, specific collections of neurons are more susceptible in each disease, resulting in characteristic patterns of pathology and clinical symptoms. One hypothesis poses that altered protein function is fundamental to pathogenesis, with protein context of the expanded polyglutamine having key roles in disease-specific processes. This review will focus on the role of the disease-causing polyglutamine proteins in gene transcription and the extent to which the mutant proteins induce disruption of transcription.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912271     DOI: 10.1101/gad.1436506

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  68 in total

Review 1.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

2.  Convergent transcription through a long CAG tract destabilizes repeats and induces apoptosis.

Authors:  Yunfu Lin; Mei Leng; Ma Wan; John H Wilson
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

3.  In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.

Authors:  Elizabeth A Thomas; Giovanni Coppola; Bin Tang; Alexandre Kuhn; SoongHo Kim; Daniel H Geschwind; Timothy B Brown; Ruth Luthi-Carter; Michelle E Ehrlich
Journal:  Hum Mol Genet       Date:  2010-12-20       Impact factor: 6.150

4.  Ubiquilin interacts and enhances the degradation of expanded-polyglutamine proteins.

Authors:  Hongmin Wang; Mervyn J Monteiro
Journal:  Biochem Biophys Res Commun       Date:  2007-06-25       Impact factor: 3.575

5.  Diverse effects of individual mismatch repair components on transcription-induced CAG repeat instability in human cells.

Authors:  Yunfu Lin; John H Wilson
Journal:  DNA Repair (Amst)       Date:  2009-06-03

6.  Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells.

Authors:  Rong Hou; Nicholas E S Sibinga
Journal:  J Biol Chem       Date:  2009-01-07       Impact factor: 5.157

Review 7.  Probing protein aggregation using discrete molecular dynamics.

Authors:  Shantanu Sharma; Feng Ding; Nikolay V Dokholyan
Journal:  Front Biosci       Date:  2008-05-01

Review 8.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

9.  Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.

Authors:  Eriko Suzuki; Yue Zhao; Saya Ito; Shun Sawatsubashi; Takuya Murata; Takashi Furutani; Yuko Shirode; Kaoru Yamagata; Masahiko Tanabe; Shuhei Kimura; Takashi Ueda; Sally Fujiyama; Jinseon Lim; Hiroyuki Matsukawa; Alexander P Kouzmenko; Toshiro Aigaki; Tetsuya Tabata; Ken-ichi Takeyama; Shigeaki Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

10.  Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies.

Authors:  Jeffrey N Savas; Anthony Makusky; Søren Ottosen; David Baillat; Florian Then; Dimitri Krainc; Ramin Shiekhattar; Sanford P Markey; Naoko Tanese
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.